D
Apogee Therapeutics, Inc. APGE
$39.94 $1.614.20%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 90.85% 79.27% 121.02% 125.20% 279.96%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 104.23% 141.46% 133.64% 201.64% 119.95%
Operating Income -104.23% -141.46% -133.64% -201.64% -119.95%
Income Before Tax -111.75% -135.21% -79.06% -156.24% -80.07%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -111.81% -135.21% -79.06% -156.24% -80.07%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -111.81% -135.21% -79.06% -156.24% -80.07%
EBIT -104.23% -141.46% -133.64% -201.64% -119.95%
EBITDA -- -- -- -- --
EPS Basic -79.03% -70.78% 84.16% 74.47% 80.28%
Normalized Basic EPS -78.97% -70.75% 84.16% 74.47% 80.28%
EPS Diluted -79.03% -70.78% 84.16% 74.47% 80.28%
Normalized Diluted EPS -78.97% -70.75% 84.16% 74.47% 80.28%
Average Basic Shares Outstanding 18.30% 37.75% 1,030.30% 903.80% 813.31%
Average Diluted Shares Outstanding 18.30% 37.75% 1,030.30% 903.80% 813.31%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings